New

Soft Tissue Allografts Market

2021

Soft Tissue Allografts Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft, Other); Application (Orthopedic, Dentistry, Wound Care, Other); End-User (Hospitals, Orthopedic Clinics, Dental Clinics, Other) and Geography

| Report Code: TIPRE00025025 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Market Insights

Soft Tissue Allografts Market 2028 By Type, Application, End-User and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Soft tissues damage can cause severe pain, their treatment varies from physiotherapy to soft tissue replacement. Doctors recommend soft tissue allografts to patients in case of surgery. Soft tissue allografts are the substitute tissues used for the reconstruction of deficient ligaments, spinal surgeries, osteochondral and other defects during knee surgeries.

MARKET SCOPE

The "Global Soft Tissue Allografts Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the soft tissue allografts market with detailed market segmentation by type, application, end-user, and geography. The report provides key statistics on the market status of the leading soft tissue allografts market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on type, the global soft tissue allografts market is segmented into cartilage allograft, tendon allograft, meniscus allograft, dental allograft, and other.
  •  On the basis of application, the market is bifurcated into orthopedic, dentistry, wound care, and other.
  •  Based on end-user, the market is segmented into hospitals, orthopedic clinics, dental clinics, and other.

MARKET DYNAMICS
Drivers:

  •  Increase in the demand for soft tissue allografts in athletics and other sports.
  •  Rise in the cases of orthopedics and dentistry-related with aging.
  •  Technological advancements in soft tissue replacement.

Restraints:

  •  High cost of treatment.
  •  Limited reimbursement and regulatory policies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The soft tissue allografts market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the soft tissue allografts market in these regions.

IMPACT OF COVID-19 ON SOFT TISSUE ALLOGRAFTS MARKET

COVID-19 initially began in Wuhan (China) in December 2019, and till now, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. With the increase in the number of COVID-19 patients in the healthcare facilities, there was decreased public mobility that significantly impacted the therapeutic and surgical procedures, as the non-essential surgical procedures were being postponed to decrease the burden on healthcare infrastructure as doctors were compelled to treat COVID patients on priority, and resulted in stepping down approach to prevent infection transmission, which affected the soft tissue allografts market growth. Moreover, stringent lockdowns, the shutdown of specialty clinics, hospitals limited operations, and conversion of some hospitals to containment facilities and treatment wards for COVID-19 patients caused disruptions in soft tissue allografts trade and supply chain. However, the market is anticipated to witness significant demand after the removal of restrictions and continuation of the surgeries in the future.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the soft tissue allografts market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from soft tissue allografts market are anticipated to have lucrative growth opportunities in the future with the rising demand for soft tissue allografts in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the soft tissue allografts market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Conmed Corporation
  •  Smith & Nephew
  •  Stryker Corporation
  •  Zimmer Biomet
  •  Integra LifeSciences Corporation
  •  Arthrex Inc.
  •  Allergan
  •  Bone Bank Allografts
  •  Xtant Medical Holdings Inc.
  •  Direct Biologics

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Soft Tissue Allografts Market - By Type
1.3.2 Soft Tissue Allografts Market - By Application
1.3.3 Soft Tissue Allografts Market - By End-User
1.3.4 Soft Tissue Allografts Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. SOFT TISSUE ALLOGRAFTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. SOFT TISSUE ALLOGRAFTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. SOFT TISSUE ALLOGRAFTS MARKET - GLOBAL MARKET ANALYSIS
6.1. SOFT TISSUE ALLOGRAFTS - GLOBAL MARKET OVERVIEW
6.2. SOFT TISSUE ALLOGRAFTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING

7. SOFT TISSUE ALLOGRAFTS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. CARTILAGE ALLOGRAFT
7.3.1. Overview
7.3.2. Cartilage Allograft Market Forecast and Analysis
7.4. TENDON ALLOGRAFT
7.4.1. Overview
7.4.2. Tendon Allograft Market Forecast and Analysis
7.5. MENISCUS ALLOGRAFT
7.5.1. Overview
7.5.2. Meniscus Allograft Market Forecast and Analysis
7.6. DENTAL ALLOGRAFT
7.6.1. Overview
7.6.2. Dental Allograft Market Forecast and Analysis
7.7. OTHER
7.7.1. Overview
7.7.2. Other Market Forecast and Analysis
8. SOFT TISSUE ALLOGRAFTS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ORTHOPEDIC
8.3.1. Overview
8.3.2. Orthopedic Market Forecast and Analysis
8.4. DENTISTRY
8.4.1. Overview
8.4.2. Dentistry Market Forecast and Analysis
8.5. WOUND CARE
8.5.1. Overview
8.5.2. Wound Care Market Forecast and Analysis
8.6. OTHER
8.6.1. Overview
8.6.2. Other Market Forecast and Analysis
9. SOFT TISSUE ALLOGRAFTS MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
9.1. OVERVIEW
9.2. END-USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. ORTHOPEDIC CLINICS
9.4.1. Overview
9.4.2. Orthopedic Clinics Market Forecast and Analysis
9.5. DENTAL CLINICS
9.5.1. Overview
9.5.2. Dental Clinics Market Forecast and Analysis
9.6. OTHER
9.6.1. Overview
9.6.2. Other Market Forecast and Analysis

10. SOFT TISSUE ALLOGRAFTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Soft Tissue Allografts Market Overview
10.1.2 North America Soft Tissue Allografts Market Forecasts and Analysis
10.1.3 North America Soft Tissue Allografts Market Forecasts and Analysis - By Type
10.1.4 North America Soft Tissue Allografts Market Forecasts and Analysis - By Application
10.1.5 North America Soft Tissue Allografts Market Forecasts and Analysis - By End-User
10.1.6 North America Soft Tissue Allografts Market Forecasts and Analysis - By Countries
10.1.6.1 Canada Soft Tissue Allografts Market
10.1.6.1.1 Canada Soft Tissue Allografts Market by Type
10.1.6.1.2 Canada Soft Tissue Allografts Market by Application
10.1.6.1.3 Canada Soft Tissue Allografts Market by End-User
10.1.6.2 Mexico Soft Tissue Allografts Market
10.1.6.2.1 Mexico Soft Tissue Allografts Market by Type
10.1.6.2.2 Mexico Soft Tissue Allografts Market by Application
10.1.6.2.3 Mexico Soft Tissue Allografts Market by End-User
10.1.6.3 US Soft Tissue Allografts Market
10.1.6.3.1 US Soft Tissue Allografts Market by Type
10.1.6.3.2 US Soft Tissue Allografts Market by Application
10.1.6.3.3 US Soft Tissue Allografts Market by End-User
10.2. EUROPE
10.2.1 Europe Soft Tissue Allografts Market Overview
10.2.2 Europe Soft Tissue Allografts Market Forecasts and Analysis
10.2.3 Europe Soft Tissue Allografts Market Forecasts and Analysis - By Type
10.2.4 Europe Soft Tissue Allografts Market Forecasts and Analysis - By Application
10.2.5 Europe Soft Tissue Allografts Market Forecasts and Analysis - By End-User
10.2.6 Europe Soft Tissue Allografts Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Soft Tissue Allografts Market
10.2.6.1.1 Germany Soft Tissue Allografts Market by Type
10.2.6.1.2 Germany Soft Tissue Allografts Market by Application
10.2.6.1.3 Germany Soft Tissue Allografts Market by End-User
10.2.6.2 France Soft Tissue Allografts Market
10.2.6.2.1 France Soft Tissue Allografts Market by Type
10.2.6.2.2 France Soft Tissue Allografts Market by Application
10.2.6.2.3 France Soft Tissue Allografts Market by End-User
10.2.6.3 Italy Soft Tissue Allografts Market
10.2.6.3.1 Italy Soft Tissue Allografts Market by Type
10.2.6.3.2 Italy Soft Tissue Allografts Market by Application
10.2.6.3.3 Italy Soft Tissue Allografts Market by End-User
10.2.6.4 Spain Soft Tissue Allografts Market
10.2.6.4.1 Spain Soft Tissue Allografts Market by Type
10.2.6.4.2 Spain Soft Tissue Allografts Market by Application
10.2.6.4.3 Spain Soft Tissue Allografts Market by End-User
10.2.6.5 United Kingdom Soft Tissue Allografts Market
10.2.6.5.1 United Kingdom Soft Tissue Allografts Market by Type
10.2.6.5.2 United Kingdom Soft Tissue Allografts Market by Application
10.2.6.5.3 United Kingdom Soft Tissue Allografts Market by End-User
10.2.6.6 Rest of Europe Soft Tissue Allografts Market
10.2.6.6.1 Rest of Europe Soft Tissue Allografts Market by Type
10.2.6.6.2 Rest of Europe Soft Tissue Allografts Market by Application
10.2.6.6.3 Rest of Europe Soft Tissue Allografts Market by End-User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Soft Tissue Allografts Market Overview
10.3.2 Asia-Pacific Soft Tissue Allografts Market Forecasts and Analysis
10.3.3 Asia-Pacific Soft Tissue Allografts Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Soft Tissue Allografts Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Soft Tissue Allografts Market Forecasts and Analysis - By End-User
10.3.6 Asia-Pacific Soft Tissue Allografts Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Soft Tissue Allografts Market
10.3.6.1.1 Australia Soft Tissue Allografts Market by Type
10.3.6.1.2 Australia Soft Tissue Allografts Market by Application
10.3.6.1.3 Australia Soft Tissue Allografts Market by End-User
10.3.6.2 China Soft Tissue Allografts Market
10.3.6.2.1 China Soft Tissue Allografts Market by Type
10.3.6.2.2 China Soft Tissue Allografts Market by Application
10.3.6.2.3 China Soft Tissue Allografts Market by End-User
10.3.6.3 India Soft Tissue Allografts Market
10.3.6.3.1 India Soft Tissue Allografts Market by Type
10.3.6.3.2 India Soft Tissue Allografts Market by Application
10.3.6.3.3 India Soft Tissue Allografts Market by End-User
10.3.6.4 Japan Soft Tissue Allografts Market
10.3.6.4.1 Japan Soft Tissue Allografts Market by Type
10.3.6.4.2 Japan Soft Tissue Allografts Market by Application
10.3.6.4.3 Japan Soft Tissue Allografts Market by End-User
10.3.6.5 South Korea Soft Tissue Allografts Market
10.3.6.5.1 South Korea Soft Tissue Allografts Market by Type
10.3.6.5.2 South Korea Soft Tissue Allografts Market by Application
10.3.6.5.3 South Korea Soft Tissue Allografts Market by End-User
10.3.6.6 Rest of Asia-Pacific Soft Tissue Allografts Market
10.3.6.6.1 Rest of Asia-Pacific Soft Tissue Allografts Market by Type
10.3.6.6.2 Rest of Asia-Pacific Soft Tissue Allografts Market by Application
10.3.6.6.3 Rest of Asia-Pacific Soft Tissue Allografts Market by End-User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Soft Tissue Allografts Market Overview
10.4.2 Middle East and Africa Soft Tissue Allografts Market Forecasts and Analysis
10.4.3 Middle East and Africa Soft Tissue Allografts Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Soft Tissue Allografts Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Soft Tissue Allografts Market Forecasts and Analysis - By End-User
10.4.6 Middle East and Africa Soft Tissue Allografts Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Soft Tissue Allografts Market
10.4.6.1.1 South Africa Soft Tissue Allografts Market by Type
10.4.6.1.2 South Africa Soft Tissue Allografts Market by Application
10.4.6.1.3 South Africa Soft Tissue Allografts Market by End-User
10.4.6.2 Saudi Arabia Soft Tissue Allografts Market
10.4.6.2.1 Saudi Arabia Soft Tissue Allografts Market by Type
10.4.6.2.2 Saudi Arabia Soft Tissue Allografts Market by Application
10.4.6.2.3 Saudi Arabia Soft Tissue Allografts Market by End-User
10.4.6.3 U.A.E Soft Tissue Allografts Market
10.4.6.3.1 U.A.E Soft Tissue Allografts Market by Type
10.4.6.3.2 U.A.E Soft Tissue Allografts Market by Application
10.4.6.3.3 U.A.E Soft Tissue Allografts Market by End-User
10.4.6.4 Rest of Middle East and Africa Soft Tissue Allografts Market
10.4.6.4.1 Rest of Middle East and Africa Soft Tissue Allografts Market by Type
10.4.6.4.2 Rest of Middle East and Africa Soft Tissue Allografts Market by Application
10.4.6.4.3 Rest of Middle East and Africa Soft Tissue Allografts Market by End-User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Soft Tissue Allografts Market Overview
10.5.2 South and Central America Soft Tissue Allografts Market Forecasts and Analysis
10.5.3 South and Central America Soft Tissue Allografts Market Forecasts and Analysis - By Type
10.5.4 South and Central America Soft Tissue Allografts Market Forecasts and Analysis - By Application
10.5.5 South and Central America Soft Tissue Allografts Market Forecasts and Analysis - By End-User
10.5.6 South and Central America Soft Tissue Allografts Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Soft Tissue Allografts Market
10.5.6.1.1 Brazil Soft Tissue Allografts Market by Type
10.5.6.1.2 Brazil Soft Tissue Allografts Market by Application
10.5.6.1.3 Brazil Soft Tissue Allografts Market by End-User
10.5.6.2 Argentina Soft Tissue Allografts Market
10.5.6.2.1 Argentina Soft Tissue Allografts Market by Type
10.5.6.2.2 Argentina Soft Tissue Allografts Market by Application
10.5.6.2.3 Argentina Soft Tissue Allografts Market by End-User
10.5.6.3 Rest of South and Central America Soft Tissue Allografts Market
10.5.6.3.1 Rest of South and Central America Soft Tissue Allografts Market by Type
10.5.6.3.2 Rest of South and Central America Soft Tissue Allografts Market by Application
10.5.6.3.3 Rest of South and Central America Soft Tissue Allografts Market by End-User

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. SOFT TISSUE ALLOGRAFTS MARKET, KEY COMPANY PROFILES
12.1. CONMED CORPORATION
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SMITH AND NEPHEW
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. STRYKER CORPORATION
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ZIMMER BIOMET
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. INTEGRA LIFESCIENCES CORPORATION
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ARTHREX INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ALLERGAN
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BONE BANK ALLOGRAFTS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. XTANT MEDICAL HOLDINGS INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. DIRECT BIOLOGICS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Conmed Corporation
2. Smith and Nephew
3. Stryker Corporation
4. Zimmer Biomet
5. Integra LifeSciences Corporation
6. Arthrex Inc.
7. Allergan
8. Bone Bank Allografts
9. Xtant Medical Holdings Inc.
10. Direct Biologics
TIPRE00025025
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.